PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: GOLDMAN SACHS GROUP INC discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Goldman Sachs Group Inc. disclosed a stake exceeding 5% in Pacific Biosciences of California Inc. via a Schedule 13G filing with the SEC (accession 0000886982-26-000587). The exact share count and percentage above the 5% threshold were not specified in the filing headline. The disclosure signals heightened institutional interest in the genetic-sequencing company and places Goldman among its major beneficial owners. Investors will watch for further 13G/13D amendments for precise position sizing and any subsequent changes in Goldman's holdings.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Goldman Sachs Group Inc. (GS), Pacific Biosciences of California, Inc.
A linked name opens that asset's sentiment page.